ACACB

Protein-coding gene in humans From Wikipedia, the free encyclopedia

Acetyl-CoA carboxylase 2 also known as ACC-beta or ACC2 is an enzyme that in humans is encoded by the ACACB gene.[5][6]

PDBOrtholog search: PDBe RCSB
AliasesACACB, ACC2, ACCB, HACC275, acetyl-CoA carboxylase beta, ACC-beta, ACCbeta, ACACbeta
Quick facts Available structures, PDB ...
ACACB
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesACACB, ACC2, ACCB, HACC275, acetyl-CoA carboxylase beta, ACC-beta, ACCbeta, ACACbeta
External IDsOMIM: 601557; MGI: 2140940; HomoloGene: 74382; GeneCards: ACACB; OMA:ACACB - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001093

NM_133904

RefSeq (protein)

NP_001084

NP_598665
NP_001390456
NP_001390457
NP_001390458

Location (UCSC)Chr 12: 109.12 – 109.27 MbChr 5: 114.28 – 114.39 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Function

Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine palmitoyltransferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis.[5]

Clinical implications

Human acetyl-CoA carboxylase has recently become a target in the design of new anti-obesity drugs.[7] However, when the gene for ACC2 was knocked out in mice, no change in body weight was observed relative to normal mice.[8] This result suggests inhibition of ACC2 by drugs may be an ineffective method of treating obesity.

References

Further reading

Related Articles

Wikiwand AI